2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy, Scott M; Stone, Neil J; Bailey, Alison L; Beam, Craig; Birtcher, Kim K; Blumenthal, Roger S; Braun, Lynne T; de Ferranti, Sarah; Faiella-Tommasino, Joseph; Forman, Daniel E; Goldberg, Ronald; Heidenreich, Paul A; Hlatky, Mark A; Jones, Daniel W; Lloyd-Jones, Donald; Lopez-Pajares, Nuria; Ndumele, Chiadi E; Orringer, Carl E; Peralta, Carmen A; Saseen, Joseph J; Smith, Sidney C; Sperling, Laurence; Virani, Salim S; Yeboah, Joseph

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy, Scott M; Stone, Neil J; Bailey, Alison L; Beam, Craig; Birtcher, Kim K; Blumenthal, Roger S; Braun, Lynne T; de Ferranti, Sarah; Faiella-Tommasino, Joseph; Forman, Daniel E; Goldberg, Ronald; Heidenreich, Paul A; Hlatky, Mark A; Jones, Daniel W; Lloyd-Jones, Donald; Lopez-Pajares, Nuria; Ndumele, Chiadi E; Orringer, Carl E; Peralta, Carmen A; Saseen, Joseph J; Smith, Sidney C; Sperling, Laurence; Virani, Salim S; Yeboah, Joseph.

J Am Coll Cardiol ; 73(24): e285-e350, 2019 06 25.

Article em En | MEDLINE | ID: mdl-30423393

Assuntos

Cardiologia; Doenças Cardiovasculares/prevenção & controle; Ezetimiba/farmacologia; Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia; Hipercolesterolemia; Inibidores de PCSK9; American Heart Association; Anticolesterolemiantes/farmacologia; Biomarcadores/sangue; Cardiologia/métodos; Cardiologia/normas; Doenças Cardiovasculares/psicologia; Humanos; Hipercolesterolemia/sangue; Hipercolesterolemia/diagnóstico; Hipercolesterolemia/epidemiologia; Hipercolesterolemia/terapia; Conduta do Tratamento Medicamentoso/normas; Medição de Risco/métodos; Comportamento de Redução do Risco; Estados Unidos

Palavras-chave

ACC/AHA Clinical Practice Guidelines; Guidelines; LDL-cholesterol; biomarkers; cardiovascular disease; cholesterol; coronary artery calcium score; diabetes mellitus; drug therapy; ezetimibe; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; pharmacological; primary prevention; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; risk assessment; risk reduction discussion; risk treatment discussion; secondary prevention

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Cardiologia / Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Ezetimiba / Inibidores de PCSK9 / Hipercolesterolemia Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google